Copyright Reports & Markets. All rights reserved.

Global Nimodipine Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nimodipine Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 50ml:10mg
    • 1.3.3 100ml:20mg
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nimodipine Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Nimodipine Injection Market Size & Forecast
    • 1.5.1 Global Nimodipine Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Nimodipine Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Nimodipine Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Nimodipine Injection Product and Services
    • 2.1.4 Bayer Nimodipine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 Cisen Pharmaceutical
    • 2.2.1 Cisen Pharmaceutical Details
    • 2.2.2 Cisen Pharmaceutical Major Business
    • 2.2.3 Cisen Pharmaceutical Nimodipine Injection Product and Services
    • 2.2.4 Cisen Pharmaceutical Nimodipine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Cisen Pharmaceutical Recent Developments/Updates
  • 2.3 Lexicare Pharma
    • 2.3.1 Lexicare Pharma Details
    • 2.3.2 Lexicare Pharma Major Business
    • 2.3.3 Lexicare Pharma Nimodipine Injection Product and Services
    • 2.3.4 Lexicare Pharma Nimodipine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Lexicare Pharma Recent Developments/Updates
  • 2.4 Actiza Pharmaceutical
    • 2.4.1 Actiza Pharmaceutical Details
    • 2.4.2 Actiza Pharmaceutical Major Business
    • 2.4.3 Actiza Pharmaceutical Nimodipine Injection Product and Services
    • 2.4.4 Actiza Pharmaceutical Nimodipine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Actiza Pharmaceutical Recent Developments/Updates
  • 2.5 Huiyu Pharmaceutical
    • 2.5.1 Huiyu Pharmaceutical Details
    • 2.5.2 Huiyu Pharmaceutical Major Business
    • 2.5.3 Huiyu Pharmaceutical Nimodipine Injection Product and Services
    • 2.5.4 Huiyu Pharmaceutical Nimodipine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Huiyu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Nimodipine Injection by Manufacturer

  • 3.1 Global Nimodipine Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Nimodipine Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Nimodipine Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Nimodipine Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Nimodipine Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Nimodipine Injection Manufacturer Market Share in 2025
  • 3.5 Nimodipine Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Nimodipine Injection Market: Region Footprint
    • 3.5.2 Nimodipine Injection Market: Company Product Type Footprint
    • 3.5.3 Nimodipine Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nimodipine Injection Market Size by Region
    • 4.1.1 Global Nimodipine Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Nimodipine Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Nimodipine Injection Average Price by Region (2021-2032)
  • 4.2 North America Nimodipine Injection Consumption Value (2021-2032)
  • 4.3 Europe Nimodipine Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Nimodipine Injection Consumption Value (2021-2032)
  • 4.5 South America Nimodipine Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Nimodipine Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Nimodipine Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Nimodipine Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Nimodipine Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Nimodipine Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Nimodipine Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Nimodipine Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Nimodipine Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Nimodipine Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Nimodipine Injection Market Size by Country
    • 7.3.1 North America Nimodipine Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Nimodipine Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Nimodipine Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Nimodipine Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Nimodipine Injection Market Size by Country
    • 8.3.1 Europe Nimodipine Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Nimodipine Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nimodipine Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Nimodipine Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Nimodipine Injection Market Size by Region
    • 9.3.1 Asia-Pacific Nimodipine Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Nimodipine Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Nimodipine Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Nimodipine Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Nimodipine Injection Market Size by Country
    • 10.3.1 South America Nimodipine Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Nimodipine Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nimodipine Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Nimodipine Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Nimodipine Injection Market Size by Country
    • 11.3.1 Middle East & Africa Nimodipine Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Nimodipine Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Nimodipine Injection Market Drivers
  • 12.2 Nimodipine Injection Market Restraints
  • 12.3 Nimodipine Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nimodipine Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nimodipine Injection
  • 13.3 Nimodipine Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nimodipine Injection Typical Distributors
  • 14.3 Nimodipine Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nimodipine Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Nimodipine Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nimodipine Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Nimodipine Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Nimodipine Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Nimodipine Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nimodipine Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nimodipine Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Cisen Pharmaceutical, Lexicare Pharma, Actiza Pharmaceutical, Huiyu Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Nimodipine Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    50ml:10mg
    100ml:20mg
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    Bayer
    Cisen Pharmaceutical
    Lexicare Pharma
    Actiza Pharmaceutical
    Huiyu Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nimodipine Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nimodipine Injection, with price, sales quantity, revenue, and global market share of Nimodipine Injection from 2021 to 2026.
    Chapter 3, the Nimodipine Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nimodipine Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nimodipine Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nimodipine Injection.
    Chapter 14 and 15, to describe Nimodipine Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now